+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Seroprevalence of Bordetella bronchiseptica and canine parainfluenza virus type 2 in dogs in Bombay

Seroprevalence of Bordetella bronchiseptica and canine parainfluenza virus type 2 in dogs in Bombay

Journal of Bombay Veterinary College 2(2): 79-82

In a survey of 80 dogs from Bombay for passive haemagglutinating antibodies to B. bronchiseptica and haemagglutination inhibiting antibodies to canine parainfluenza virus type 2, overall seroprevalence was 48.7% and 73.8% respectively.

(PDF 0-2 workdays service: $29.90)

Accession: 002219586

Download citation: RISBibTeXText

Related references

Seroepidemiology of respiratory (group 2) canine coronavirus, canine parainfluenza virus, and Bordetella bronchiseptica infections in urban dogs in a humane shelter and in rural dogs in small communities. Canadian Veterinary Journal 52(8): 861-868, 2012

Seroepidemiological survey of Bordetella bronchiseptica and canine parainfluenza-2 virus in dogs in Sweden. Veterinary Record 152(9): 251-254, 2003

Protection of dogs for 13 months against Bordetella bronchiseptica and canine parainfluenza virus with a modified live vaccine. Veterinary Record 157(1): 19-23, 2005

Role of canine parainfluenza virus and Bordetella bronchiseptica in kennel cough. American Journal of Veterinary Research 45(9): 1862-1866, 1984

Reinfection of beagle dogs with canine parainfluenza ii and bordetella bronchiseptica does not produce airway hyperreactivity or changes in bronchoalveolar lavage fluid. American Review of Respiratory Disease 133(4 SUPPL): A299, 1986

Canine parainfluenza type 2 and Bordetella bronchiseptica infection produces increased bronchoalveolar lavage thromboxane concentrations in beagle puppies. Prostaglandins, Leukotrienes, and Essential Fatty Acids 44(3): 171-175, 1991

Duration of serological response to canine parvovirus-type 2, canine distemper virus, canine adenovirus type 1 and canine parainfluenza virus in client-owned dogs in Australia. Australian Veterinary Journal 90(12): 468-473, 2013

Canine parainfluenza-Bordetella bronchiseptica vaccine immunogenicity. American Journal of Veterinary Research 42(2): 266-270, 1981

Canine distemper virus infection with secondary Bordetella bronchiseptica pneumonia in dogs. Ciencia Rural 29(4): 741-743, 1999

Seroepidemiological survey of canine distemper, canine parvovirus, canine coronavirus, canine adenovirus type-2, and canine parainfluenza virus infections of dogs by an indirect immunofluorescent test. Korean Journal of Veterinary Research 35(1): 75-85, 1995

Field evaluation of an intranasally administered canine parainfluenza-Bordetella bronchiseptica vaccine. Veterinary Medicine, Small Animal Clinician 75(6): 1003-1005, 1980

Lung growth is not altered by canine parainfluenza 2 and bordetella bronchiseptica infections in beagle puppies. American Review of Respiratory Disease 133(4 SUPPL): A189, 1986

Hepatocellular necrosis associated with the subcutaneous injection of an intranasal Bordetella bronchiseptica-canine parainfluenza vaccine. Journal of the American Animal Hospital Association 33(2): 126-128, 1997

Canine infectious tracheobronchitis: effects of an intranasal live canine parainfluenza-Bordetella bronchiseptica vaccine on viral shedding and clinical tracheobronchitis (kennel cough). American Journal of Veterinary Research 42(10): 1694-1698, 1981

Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine. American Journal of Veterinary Research 40(9): 1241-1243, 1979